NAD+ IV Therapy
NAD+ IV therapy is a specialty infusion service that involves administering nicotinamide adenine dinucleotide (NAD+) directly into the bloodstream. Before scheduling, it is essential to understand what this treatment is, what it is not, and how it may be tailored to your individual needs.
A consultation is required to discuss your goals, health history, medications, and any previous infusion experiences. This conversation helps determine whether NAD+ IV therapy is appropriate for you and what you can realistically expect from the experience.
A consultation-led approach to NAD+ IV therapy
- A provider-led discussion to understand your goals and health history
- Review of evidence and proposed protocol before treatment
- Monitoring and tolerability assessment during the infusion
- Clear guidance on preparation, aftercare, and realistic expectations
Understanding
NAD+
NAD+ plays a role in cellular processes, including energy metabolism. However, its biological function does not automatically translate to a specific outcome from an IV infusion. The decision to consider NAD+ IV therapy should be based on a clear understanding of the proposed treatment, the evidence supporting its use, and a realistic discussion of what it may or may not address.
During your consultation, your provider will explain the proposed protocol, review your medical history, and discuss potential risks and benefits. This conversation is essential because IV-site complications, infusion-related symptoms, and individual tolerance can vary widely from person to person.
A personalized approach to NAD+
Understand the Science and the Consultation Process.
A NAD+ IV therapy conversation should separate established biology from the evidence for the treatment being proposed. Your goals, health, and tolerance should guide the decision, not an assumed protocol.
01 — Consultation
Discuss why you are considering NAD+ IV therapy, your current symptoms, health history, medications, and any previous infusion experiences.
02 — Evaluation
Review the evidence for the proposed use, the specific product, and risks relevant to your health.
03 — Personalized Plan
Clarify the proposed protocol, monitoring, comfort measures, alternatives, and consent before treatment.
04 — Ongoing Care
Review tolerability and any ongoing symptoms, and reassess the rationale before considering further infusions.
A Considered Approach to NAD+ IV Therapy.
At Basis, ask for a specific explanation of what NAD+ IV therapy is intended to do and what is not established. Confirm how uncomfortable symptoms would be assessed and when treatment would be adjusted or stopped.
What to expect
Before your appointment
Bring your medicine and supplement list and share heart, kidney, or other significant conditions. Confirm the proposed protocol and allow for the longer estimated appointment.
During your visit
Review consent and monitoring before a peripheral IV if suitable. Tell the provider promptly about nausea, pressure, cramping, dizziness, or any new symptom instead of pushing through discomfort.
Estimated visit: 90–180 min.
Confirm appointment details when booking.
After your visit
Follow individualized aftercare and report persistent or unexpected symptoms. Do not assume an immediate subjective feeling establishes benefit or that a fixed series is needed.
Frequently Asked Questions
NAD+ IV therapy is a specialty infusion service that involves administering nicotinamide adenine dinucleotide (NAD+) directly into the bloodstream. Its biological role does not by itself prove a benefit from intravenous supplementation.
A longevity benefit should not be assumed. Ask what human clinical evidence supports the exact proposed use and what remains unknown.
These effects are not guaranteed, and persistent symptoms may have other causes. A medical review may be more useful than attributing them to NAD+ levels.
The provider should explain the proposed preparation and individualized plan before consent.
Estimated visit: 90–180 min. Confirm appointment details when booking. Assessment and individual tolerability may change the time needed. Confirm the planned preparation, monitoring, and observation before attending.
Report symptoms promptly so the provider can assess them. Discomfort should not be treated as proof that the infusion is working or something you must endure.
An IV preparation and oral precursor products are different interventions. Evidence, risks, and findings for one should not be automatically applied to the other.
Ask whether repeat infusions have a justified purpose and how safety and response would be reviewed.
It’s time to get back to basis.
Talk with a provider about NAD+ IV therapy, its proposed protocol, and the evidence relevant to your goals.